

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Note: The revised North American Free Trade Agreement (NAFTA) goes into effect today, July 1. The U.S. Senate passed the new NAFTA in January 2020 by a margin of 89 to 10 after the U.S. House of Representatives voted by a margin of 385 to 41 in December 2019.
On paper the new NAFTA--with improved labor terms added and extreme Big Pharma monopolies and ISDS investor rights removed -- is better than the original, but it won't benefit people unless it's effectively enforced.
It's a terrible start that on Day One of a deal Trump said would transform trade, a leading Mexican labor lawyer has spent weeks in jail on trumped up charges for helping workers use USMCA's labor rights and Mexico's new USMCA--compliant labor law is bogged down by hundreds of lawsuits aimed at derailing it.
Maybe Trump hoped to distract from myriad failures by spotlighting the new NAFTA on July 1, but it's also the date that 100 of the 600 legal challenges against the pact's labor rights rise to Mexico's Supreme Court and Susana Prieto, a famous Mexican labor lawyer detained for weeks for helping workers organize a union, has a high visibility hearing.
Meanwhile, Trump's claims that the new NAFTA will restore hundreds of thousands of manufacturing jobs have proved baseless as U.S. auto firms announced plans to increase production in Mexico from Ford's Mustang electric SUV to GM closing U.S. plants and moving popular vehicle lines to Mexico. But the U.S. Department of Labor has certified more than 175,000 Americans as losing jobs to trade during the Trump administration's first years while the NAFTA trade deficit jumped 88% under Trump.
The new NAFTA's greatest impact may be that it began a long overdue rethink of the U.S. trade-pact model. The unusually large, bipartisan congressional votes on the new NAFTA showed that to be viable today, U.S. trade pacts no longer can include extreme corporate investor privileges or broad monopolies for Big Pharma and must have enforceable labor and environmental standards. The 2016 Trans-Pacific Partnership, which failed these tests, never got close to majority congressional support.
Renegotiating the existing NAFTA to try to reduce its ongoing damage is not the same as crafting a good trade deal that creates jobs, raises wages and protects the environment and public health. The new NAFTA is not a template, but rather sets the floor from which we will fight for trade policies that put working people and the planet first. Any new trade deals must include climate standards, stronger rules to stop race-to-the-bottom outsourcing of jobs and pollution, and enforceable rules against currency misvaluation and not limit protections needed to ensure our food and products are safe, our privacy is protected and big banks do not crash the economy.
BACKGROUND INFO
Susana Prieto Terrazas, a well-known Mexican labor lawyer, has been locked up since June 8 for trying to use the core labor right guaranteed by the revised NAFTA and Mexico's new labor law; a July 1 hearing is scheduled after several punitive bail denials. Prieto, a key advocate for exploited workers in border maquiladora factories in Matamoros and Juarez, has been held without bail for three weeks on trumped-up charges of "mutiny, threats and coercion" after trying to register an independent union to replace a corrupt "protection" union in Matamoros. Prieto became well-known in Mexico for helping maquiladora workers win higher wages in factories along the Texas border last year. Recently, she supported workers demanding COVID-19 safety measures after dozens of maquiladora workers died from workplace coronavirus exposure. Wildcat strikes and mass protests have grown throughout the border region as U.S. companies and officials push for plants to reopen without safety measures. Dozens of members of the U.S. House of Representatives sent a letter yesterday demanding Prieto's release. At June 17 hearings, members of Congress raised concerns about Prieto's arrest with the U.S. Trade Representative, who confirmed he was closely following her case and found it a "bad indicator" of compliance with NAFTA's revised labor standards. Prieto livestreamed her arrest as she tried to register the Independent Union of Industrial and Service Workers "Movimiento 20/32," chosen by workers to replace a "protection" union. Last week, Prieto's daughter delivered a letter from U.S. unions and civil society groups to the Mexican National Human Rights Commission seeking help on Prieto's release. U.S. fair trade activists will deliver the letter to Mexican consulates nationwide on July 1. After decades of worker intimidation, Mexican manufacturing wages are now 40% lower than those in China. The Department of Labor has certified more than one million U.S. jobs (1,015,948) as lost to NAFTA just under one narrow retraining program called Trade Adjustment Assistance, which represents a significant undercount of total jobs lost.*
The first 100 of 600 challenges to Mexico's new labor law will hit Mexico's Supreme Court on its July 1 reopening. The new NAFTA requires that "protection" contracts signed by unions not elected by workers all be reviewed and that contracts be approved directly by workers within four years after the revised NAFTA goes into effect. This requirement is at the heart of the reforms to Mexico's labor laws enacted on May 1, 2019. Under the new labor law, workers in Mexico could finally have legal protections to fight to raise abysmally low wages. This would also reduce incentives to outsource U.S. jobs to Mexico, benefiting U.S. workers. Within weeks of the new law's enactment, hundreds of corrupt local "protection" unions and other interests opposed to reform began to file what are now more than 600 lawsuits, which both try to block the law's application to specific union contracts and workplaces and to gut the law altogether on grounds that it is unconstitutional. Mexico's judiciary has been out of session since mid-March for COVID-19 precautions. On July 1, the court system goes back into operation, with the first 100 challenges hitting Mexico's Supreme Court. If the court rules against the challenged terms, Mexico will be in violation of NAFTA labor obligations that are essential if the new deal is to slow U.S. job outsourcing. This memo has the latest updates on the cases.
The Department of Labor has certified 176,982 trade-related job losses during Trump's presidency, and the manufacturing sector is hurting. Under the narrow Trade Adjustment Assistance worker training program alone, 176,982 workers have been certified as losing jobs to trade since the 2017 start of the Trump administration. The data mainly covers 2017-2018, as there is typically a 12-18 month gap between layoff dates and certification. Whether the new NAFTA can slow ongoing job outsourcing or the 88% increase in the overall NAFTA trade deficit during the Trump administration remains to be seen over time. What is clear now is that the U.S. manufacturing sector has been severely harmed by the ongoing COVID-19 pandemic, with 1.1 million manufacturing jobs lost in May 2020 compared with the same month last year.
*Data Note: The trade data is sourced from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau. We present deficit figures adjusted for inflation to the base month of May 2020. The overall percentage change in the U.S.-NAFTA trade deficit under Donald Trump represent the change in total goods and services trade deficit since 2016, Barack Obama's last year, and 2019, the last full year of data available during the Trump administration. Manufacturing job data is sourced from the U.S. Bureau of Labor Statistics. The government-certified job loss data is sourced from Public Citizen's Trade Adjustment Assistance (TAA) Database. The U.S. Department of Labor certified trade-impacted workplaces under its TAA program. This program provides a list of trade-related job losses and job retraining and extended unemployment benefits to workers who lose jobs to trade. TAA is a narrow program, covering only a subset of workers who lose jobs to trade. It does not provide a comprehensive list of facilities or jobs that have been offshored or lost to import competition. Although the TAA data represent a significant undercount of trade-related job losses, TAA is the only government program that provides information about job losses officially certified by the U.S. government to be trade-related. Public Citizen provides an easily searchable version of the TAA database. Please review our guide on how to interpret the data here and the technical documentation here.
Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people - not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.
(202) 588-1000"Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations."
A report released Tuesday by Democrats on the Senate Finance Committee details how US President Donald Trump and Republicans in Congress are waging a multifront war on children by targeting healthcare programs, education, and nutrition assistance as part of their scorched-earth assault on the nation's safety net and redistribution of wealth to the very top.
"In just months, the Trump administration has gutted access to healthcare for millions of children, slashed funding for school meals and nutrition assistance, fired thousands of workers dedicated to advancing child welfare and protecting children, and unleashed policies that traumatize and harm immigrant families and LGBTQ+ youth," reads the report. "These actions are not isolated—they reflect a coordinated agenda that will leave a generation of children sicker, hungrier, and less safe."
As part of the sprawling budget reconciliation package that Trump signed into law over the summer, Republicans enacted the largest-ever cuts to Medicaid and the Supplemental Nutrition Assistance Program (SNAP), slashing more than $1 trillion combined from the two programs.
Roughly half of all kids in the US are covered by either Medicaid or the Children's Health Insurance Program, and around 40% of SNAP beneficiaries are children, meaning cuts to those programs will have far-reaching impacts on the nation's youth in the coming years.
"By making the largest cuts to healthcare and food assistance in the nation’s history, Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations," Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee, said in a statement on Tuesday.
"By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
In addition to denouncing cuts to Medicaid and SNAP, the new report outlines how the Trump administration is imperiling mental health programs by canceling grants and other funding, harming children's education by throttling Head Start funds, and inflicting deadly cuts to programs that aid kids overseas—all while delivering massive tax cuts to the richest Americans and largest corporations.
"Trump’s cuts to healthcare access, food assistance, and education have stripped millions of kids of the care, nutrition, and protection they need to thrive," the report states. "By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
"Unless stopped," the report concludes, "Trump’s war on kids will leave lasting scars on millions of children and weaken the nation for decades to come."
"He’s not thinking about the democratization of Venezuela, let alone the narco-trafficking," said the Latin American leader. "In general, all of the wars of this century had to do with oil."
Colombian President Gustavo Petro said Tuesday that US President Donald Trump's central focus with his attacks and threats against Venezuela is the desire for the nation's vast oil reserves and little if anything to do with stopping illegal drug trafficking or improving the nation's democratic prospects under President Nicolas Maduro.
In an face-to-face interview with CNN's Isa Soeres, which the correspondent described as "fiery" at times, Petro explained that Venezuela's oil reserves, among the largest in the world, is "at the heart of the matter" when it comes to Trump's repeated extrajudicial killings in waters of the nation's coast this year and a broader military buildup that includes deployment of the USS Gerald R. Ford aircraft carrier group and mobilization of US Southern Command.
"What lies behind this," said Petro, "is the same thing behind the war in Ukraine... petroleum," noting the size and quality of Venezuela's reserves. "In general, all of the wars of this century had to do with oil."
If Trump were to get the upper hand, Petro suggested, the United States would get Venezuela's oil "almost for free," predicting that—"based on the evidence so far"—that the US will go to war over the resources.
Trump, said Petro, "is not thinking about the democratization of Venezuela, let alone the narco-trafficking," adding that Venezuela is not considered a major drug producer or transit point for most narcotics headed to the United States.
"You only have to look at the numbers," said Petro. "Only about 4 percent of Colombia's cocaine production... goes through Venezuela—a small margin—while most of it goes out through the Pacific Ocean."
As CNN notes, "Petro has been at odds with Trump since he returned to the White House. In the past year, the Colombian leader has harshly criticized the Trump administration’s immigration policies, its support for Israel and its military activity around Latin America."
In September, the US State Department under Trump had Petro's visa revoked following critical comments he made during the UN General Assembly in New York.
This week, the US designated a new group, the Cartel do Los Soles, as a terrorist organization, naming Maduro its de facto leader, a claim that experts say there is no evidence to support.
Asked by CNN if he assesses Maduro as a gang leader, dictator, or narcotrafficker, Petro said investigations in Colombia have never shown Maduro to be connected to the black market drug trade and that his country's data doesn't even show the existence of the alleged cartel designated this week by the Trump administration.
"The problem of Maduro," said Petro, "is lack of democracy and dialogue."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," said one Democratic senator.
The Trump administration on Tuesday announced newly negotiated prices for more than a dozen prescription drugs covered by Medicare, an achievement made possible by a Biden-era law that has faced relentless attacks from the pharmaceutical industry, GOP lawmakers, and the Republican president.
The announcement marks the end of the second round of Medicare drug price negotiations required under the Inflation Reduction Act (IRA), a measure passed in 2022 without the support of a single Republican in Congress. Last year, House GOP leaders said the law was "disastrous" and decried what they called "the mandate from bureaucrats to artificially set prescription drug prices."
The new list contains 15 drugs, including the diabetes and weight loss medication Ozempic, the breast cancer drug Ibrance, and the prostate cancer drug Xtandi. The Centers for Medicare & Medicaid Services (CMS) estimated that if the new prices—which take effect in 2027—had been in effect last year, Medicare would have saved $12 billion.
President Donald Trump campaigned on rolling back the IRA, which for the first time allowed Medicare to negotiate drug prices directly with pharmaceutical companies. Since taking office, Trump has taken steps to weaken the law, including by signing a measure that will exempt certain high-priced drugs from Medicare negotiations—a multibillion-dollar handout to Big Pharma.
But in statements on Tuesday, Trump-appointed officials hailed the newly negotiated prices. Robert F. Kennedy Jr., secretary of the Health and Human Services Department, said the negotiation results stemmed from a Trump directive to "stop at nothing to lower healthcare costs for the American people."
CMS Administrator Mehmet Oz declared that the second round of negotiations was more successful than the first, which was held under the Biden administration. Experts said that claim is specious at best.
Democratic lawmakers were quick to highlight Republican opposition to the IRA, and continued attacks on the law, in response to the newly negotiated prices.
"Democrats took on Big Pharma by giving Medicare the power to negotiate on behalf of the tens of millions of seniors that want lower drug prices while every Republican voted against it,” said Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee. “Today’s announcement is a result of that effort by Democrats to lower health costs for older Americans."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," Wyden added. "Republicans neutered future Medicare drug price negotiations by adding delays and exemptions to some of the most expensive drugs, especially cancer drugs like Keytruda."
Tuesday's announcement came less than a week after the pharmaceutical industry suffered its 16th defeat in court as it continues its legal campaign against the Medicare price negotiations. The industry is also lobbying aggressively in support of legislation that would further weaken the IRA price-negotiation provisions.
"Drug corporations already secured a $9 billion giveaway from President Trump and congressional Republicans paid for by taxpayers and cancer patients through the Big Ugly Bill, and they are trying to go even further to delay and exempt price negotiations for more blockbuster drugs," said Steve Knievel, access to medicines advocate at Public Citizen.
"Policymakers must reject these efforts to undermine Medicare drug price negotiations," Knievel added. "Instead they should build on the program’s success by providing everyone access to negotiated prices, negotiating lower prices for more drugs sooner, and ensuring drug corporations can no longer rip us off by charging the highest prices in the world for medications."